Feedback / Questions
ES2B-C001 - ExpreS2ion
https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-dosing-of-first-patient-in-phase-i-clinical-trial-of-es2b-c001--its-novel-thera,c4167465
Jun 23, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next